Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
Meta Platforms (Facebook)
META
|
+$446M |
| 3 |
Johnson & Johnson
JNJ
|
+$306M |
| 4 |
Evergy
EVRG
|
+$288M |
| 5 |
Walmart Inc
WMT
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$596M |
| 2 |
Booking.com
BKNG
|
+$519M |
| 3 |
Amazon
AMZN
|
+$518M |
| 4 |
Eli Lilly
LLY
|
+$268M |
| 5 |
UnitedHealth
UNH
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.51% |
| 2 | Technology | 14.39% |
| 3 | Financials | 11.76% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Real Estate | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Vanguard Global ex-US Real Estate ETF
VNQI
$3.51B
| $819K | ﹤0.01% |
14,100
-3,600
| -20% | -$219K |
|
|
DVCR
2677
DELISTED
Diversicare Healthcare Services Inc
DVCR
| $819K | ﹤0.01% |
120,399
+5,699
| +5% | +$39.9K |
|
|
TUES
2678
DELISTED
Tuesday Morning Corp
TUES
| $818K | ﹤0.01% |
268,098
+176,198
| +192% | +$569K |
|
2679
Vanguard Mid-Cap Value ETF
VOE
$23.9B
| $817K | ﹤0.01% |
7,400
-600
| -8% | -$66.4K |
|
2680
Zedge
ZDGE
$38.3M
| $817K | ﹤0.01% |
217,194
+4,400
| +2% | +$16.5K |
|
2681
Vanguard Small-Cap Value ETF
VBR
$37.2B
| $815K | ﹤0.01% |
6,001
-4,200
| -41% | -$564K |
|
2682
Minerals Technologies
MTX
$2.29B
| $814K | ﹤0.01% |
10,800
-7,800
| -42% | -$562K |
|
2683
Compugen
CGEN
$212M
| $808K | ﹤0.01% |
244,900
-35,400
| -13% | -$133K |
|
|
CALA
2684
DELISTED
Calithera Biosciences, Inc
CALA
| $808K | ﹤0.01% |
8,080
-5,415
| -40% | -$613K |
|
2685
NI Holdings
NODK
$320M
| $807K | ﹤0.01% |
+47,600
| New | +$785K |
|
2686
iShares Russell Mid-Cap ETF
IWR
$55.9B
| $806K | ﹤0.01% |
15,200
+3,200
| +27% | +$168K |
|
|
ATXS
2687
DELISTED
Astria Therapeutics
ATXS
| $801K | ﹤0.01% |
13,915
-1,955
| -12% | -$180K |
|
|
NWHM
2688
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $799K | ﹤0.01% |
80,100
-79,600
| -50% | -$818K |
|
2689
Tonix Pharmaceuticals
TNXP
$152M
| – | – |
0
| – | – |
|
2690
State Street SPDR ICE Preferred Securities ETF
PSK
$689M
| $793K | ﹤0.01% |
18,239
+10,300
| +130% | +$443K |
|
|
SLCT
2691
DELISTED
Select Bancorp, Inc.
SLCT
| $791K | ﹤0.01% |
58,700
-82
| -0.1% | -$1.08K |
|
2692
AMREP Corp
AXR
$124M
| $785K | ﹤0.01% |
110,080
+3,500
| +3% | +$25K |
|
|
VOXX
2693
DELISTED
VOXX International Corporation Class A
VOXX
| $781K | ﹤0.01% |
144,641
-48,859
| -25% | -$258K |
|
|
IRS
2694
IRSA Inversiones y Representaciones
IRS
$1.31B
| $776K | ﹤0.01% |
46,617
-36,130
| -44% | -$741K |
|
2695
Mega Matrix
MPU
$16.5M
| $772K | ﹤0.01% |
243,500
+14,500
| +6% | +$44.2K |
|
2696
YPF
YPF
$19.7B
| $766K | ﹤0.01% |
+56,374
| New | +$1.1M |
|
2697
Tredegar Corp
TG
$260M
| $761K | ﹤0.01% |
+32,400
| New | +$683K |
|
2698
VanEck Oil Services ETF
OIH
$1.97B
| $754K | ﹤0.01% |
+1,435
| New | +$768K |
|
|
CASM
2699
DELISTED
CAS Medical Systems, Inc.
CASM
| $754K | ﹤0.01% |
386,539
+123,939
| +47% | +$185K |
|
2700
Protara Therapeutics
TARA
$214M
| $751K | ﹤0.01% |
7,662
+1,759
| +30% | +$164K |
|
Similar funds
Renaissance Technologies's Q2 2018 Portfolio in Review
As of Q2 2018, Renaissance Technologies held 3,750 positions worth $91.7B, up 0.34% from $91.4B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies withdrew a net $3.9B in Q2 2018, closing 524 positions and reducing 1,111 holdings. Its most notable exit was Booking.com, an estimated $519M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, Renaissance Technologies opened a new position in Apple worth $707M.
- Renaissance Technologies's largest Q2 2018 buy was Apple: 15,275,332 shares worth $707M.
- Renaissance Technologies added most to Johnson & Johnson in Q2 2018, an estimated $306M increase.
- Renaissance Technologies's biggest Q2 2018 reduction was Home Depot, cutting an estimated $596M.
- Renaissance Technologies fully exited Booking.com in Q2 2018, selling an estimated $519M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $91.7B portfolio in Q2 2018.
- Renaissance Technologies opened 412 new positions and closed 524 in Q2 2018.
- Renaissance Technologies's portfolio value rose 0.34% quarter-over-quarter to $91.7B.
Based on Renaissance Technologies's 13F filing for Q2 2018, filed 13 Aug 2018.